ATF-HI-8

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameATF-HI-8
Drug Alias Nameurokinase/urinary trypsin inhibitor chimera (Nissin/Hamamatsu University)ATF-HI-8
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUrokinase plasminogen activator inhibitorsTrypsin inhibitors
TargetsUrokinase plasminogen activatorTrypsin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNissin Foods Holdings
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHamamatsu University School Of MedicineNissin Foods Holdings
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A